Cannabis Market Intelligence For Executives & Investors
Daily Briefing
This Cannabis Giant Plans Nevada Registration, Here’s What Shareholders And Investors Need To Know

TerrAscend Extends Cash Flow Streak To 15 Quarters As Growth Returns, Shares Pop

Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect

Announcements
DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities

Chicago Capital Cannabis Conference
New Jersey Cannabis Market Spotlight
Click on the upper right section of the video to navigate the full playlist
Interviews
Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck

Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect

EXCLUSIVE: Safe Harbor Launches First Cannabis‑Ready 401K Plan

Rescheduling Raises a Big Question: Is the DEA Poised To Become the Nation’s Biggest Weed Dealer?

Cannabis Rescheduling Leaves Key Gaps: What Industry Leaders Say Still Needs Fixing

Florida Cannabis Dispensaries Reach 757: What Industry Sources Are Seeing on the Ground

Deals
Missouri Bets On Marijuana Research As It Opens Unlimited Licensing Pathway
Decibel Cannabis Stock Up After Strong 2025 Results, 484% YoY International Sales Growth
Curaleaf Rolls Out $83M Buyback Plan Ahead Of Q1 Results
Only 0.1% of the UK has a Cannabis Prescription, Tilray Just Bought Into the Other 99.9%
Aurora Cannabis Snaps Up This Cultivator In $26.5M Expansion Play
This $113M Cannabis Deal Gave Vireo Growth a Blueprint for Cost Efficiency — Here’s How

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities
Astec Announces Quarterly Dividend

Cannabis Stocks Surge As Trump Administration Signals Marijuana Reclassification
Is This Red State Turning Purple? Democrat Gov. Candidate Makes Marijuana Reform A Campaign Issue
Missouri Bets On Marijuana Research As It Opens Unlimited Licensing Pathway
Another State Joins Wave Of Bringing Medical Cannabis Into End-Of-Life Care Amid National Longevity Care Shift
Cannabis Enters Longevity Care As Oregon Allows Use In Hospice And Palliative Settings
TerrAscend Recruits This Retail Veteran As New CFO To Support Next Phase Of Growth
PA Budget Banks on Cannabis Revenue Before the Market Opens; What the Industry Is Saying

Real-Time Cannabis Intelligence That Moves Capital
IGNITE IT delivers institutional-grade cannabis market intelligence in real time. From breaking news and regulatory shifts to capital flows and operator performance, we surface the data that serious investors and decision-makers need before the market reacts.
Built for speed, accuracy, and clarity, our platform cuts through noise and eliminates information gaps in one of the fastest-moving industries in the world.
Where Industry Expertise Meets Market Momentum
Backed by seasoned financial journalists, cannabis industry veterans, and media leaders, IGNITE IT combines deep sector expertise with real-time analysis. We don’t just report market activity, we contextualize it so decision-makers can act with confidence.
Beyond intelligence, IGNITE IT connects the industry through high-impact events that bring capital, operators, and innovators into the same room.


















